Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evotec AG (EVO – Research Report), Collegium Pharmaceutical (COLL – Research Report) and Fortrea Holdings Inc. (FTRE – Research Report).
Evotec AG (EVO)
Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Evotec AG yesterday and set a price target of $13.00. The company’s shares closed last Wednesday at $10.51.
According to TipRanks.com, Ryskin is a 4-star analyst with an average return of
Evotec AG has an analyst consensus of Moderate Buy, with a price target consensus of $17.00.
See the top stocks recommended by analysts >>
Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical received a Hold rating and a $37.00 price target from Jefferies analyst Glen Santangelo today. The company’s shares closed last Wednesday at $33.86, close to its 52-week high of $34.96.
According to TipRanks.com, Santangelo is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Collegium Pharmaceutical with a $34.00 average price target.
Fortrea Holdings Inc. (FTRE)
Jefferies analyst David Windley initiated coverage with a Buy rating on Fortrea Holdings Inc. today and set a price target of $44.00. The company’s shares closed last Wednesday at $33.30.
According to TipRanks.com, Windley is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Fortrea Holdings Inc. with a $36.20 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EVO:
